This statistic presents the forecast of Earnings Before Interest, Tax, Depreciation and Amortization (EBITDA) of Merck & Co for 2021 and 2022. The EBITDA of Merck & Co was expected to amount to approximately 19.6 billion U.S. dollars in 2021.
Forecast of EBITDA of Merck & Co in 2021 and 2022 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Merck & Co.
Global positioning
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top global pharmaceutical companies based on pharma revenue 2022
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2024
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Basic Statistic Top drugs based on projected 2024 global sales
Key company data
5
Segments and products
5
- Premium Statistic Pharmaceutical revenue of Merck & Co by therapy class 2023
- Premium Statistic Merck & Co. - revenues by region 2019-2023
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Premium Statistic Merck & Co.'s Keytruda revenue 2014-2023
- Premium Statistic Sales forecast of top selling drugs worldwide 2028
Competitors
5
Research and development
5
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Premium Statistic R&D spending share of top pharmaceutical companies 2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
- Basic Statistic AI readiness of big pharma companies 2023
Further related statistics
10
- Value of global financial assets 1990-2013
- Structure of investment portfolio of Allianz Group 2014-2023
- Rio Tinto's net income 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Value of assets managed by global ETFs 2010-2017, by region
- Number of mutual funds worldwide 2011-2014, by country
- Senior chief financial officer salary per annum in Switzerland 2023
- BayWa's revenue by segment 2010-2022
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Syngenta's sales in the crop protection segment worldwide 2013-2022
Further Content: You might find this interesting as well
Statistics
- Value of global financial assets 1990-2013
- Structure of investment portfolio of Allianz Group 2014-2023
- Rio Tinto's net income 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Value of assets managed by global ETFs 2010-2017, by region
- Number of mutual funds worldwide 2011-2014, by country
- Senior chief financial officer salary per annum in Switzerland 2023
- BayWa's revenue by segment 2010-2022
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Syngenta's sales in the crop protection segment worldwide 2013-2022
Quandl. (October 19, 2021). Forecast of EBITDA of Merck & Co in 2021 and 2022 (in million U.S. dollars) [Graph]. In Statista. Retrieved June 17, 2024, from https://www.statista.com/statistics/633362/forecast-of-ebitda-of-merck-and-co/
Quandl. "Forecast of EBITDA of Merck & Co in 2021 and 2022 (in million U.S. dollars)." Chart. October 19, 2021. Statista. Accessed June 17, 2024. https://www.statista.com/statistics/633362/forecast-of-ebitda-of-merck-and-co/
Quandl. (2021). Forecast of EBITDA of Merck & Co in 2021 and 2022 (in million U.S. dollars). Statista. Statista Inc.. Accessed: June 17, 2024. https://www.statista.com/statistics/633362/forecast-of-ebitda-of-merck-and-co/
Quandl. "Forecast of Ebitda of Merck & Co in 2021 and 2022 (in Million U.S. Dollars)." Statista, Statista Inc., 19 Oct 2021, https://www.statista.com/statistics/633362/forecast-of-ebitda-of-merck-and-co/
Quandl, Forecast of EBITDA of Merck & Co in 2021 and 2022 (in million U.S. dollars) Statista, https://www.statista.com/statistics/633362/forecast-of-ebitda-of-merck-and-co/ (last visited June 17, 2024)
Forecast of EBITDA of Merck & Co in 2021 and 2022 (in million U.S. dollars) [Graph], Quandl, October 19, 2021. [Online]. Available: https://www.statista.com/statistics/633362/forecast-of-ebitda-of-merck-and-co/